XML 38 R31.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Narrative) (Details) (USD $) In Millions, unless otherwise specified | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 Cvs Caremark Corporation Member | Mar. 31, 2014 Pharmaceutical Walgreens Co Member | Jun. 30, 2013 Pharmaceutical Walgreens Co Member
Concentration Risk [Line Items] |  |  |  |  |  |
Contract expiration date |  |  |  |  | Aug. 31, 2013 |
Revenue, Major Customer, Percentage |  |  |  |  |  | 20.00%
Expected JV Operational Date |  |  |  | Jul. 01, 2014 |  |
Term of Agreement |  |  |  | 10 years |  |
Quarterly joint venture payment |  |  |  | $ 25 |  |
Proceeds from sale of other investments | 47 | 47 | 0 |  |  |
Gain on sale of investments | $ 32 | $ 32 | $ 0 |  |  |

X
- Definition Contract expiration date + References No definition available. + Details
Name: | cah_ContractExpirationDate
Namespace Prefix: | cah_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The earliest date of which the U.S.-based generic sourcing entity (Sourcing JV) with CVS is expected to be operational. + References No definition available. + Details
Name: | cah_ExpectedJVOperationalDate
Namespace Prefix: | cah_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition An expected quarterly payment over the term of the Sourcing JV that the company will pay to CVS. To begin upon completion of final documentation and customary closing conditions. + References No definition available. + Details
Name: | cah_Quarterlyjointventurepayment
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Initial term of the agreement for the U.S.-based generic sourcing entity (Sourcing JV) with CVS. + References No definition available. + Details
Name: | cah_TermofAgreement
Namespace Prefix: | cah_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale. + References No definition available. + Details
Name: | us-gaap_GainOnSaleOfInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow associated with the sale of other investments not otherwise defined in the taxonomy. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromSaleOfOtherInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration